PSMA PET/CT Beyond the Images: The Imager’s and Clinician's Perspective
DÉTAILS DE L’ACTIVITÉ
CRÉDITS
[scroll down to register]
Program Chair:
Bobby Shayegan | Chair, CUA Guidelines Committee
Update of the Canadian Landscape
Invited Speakers & Canadian Guideline Authors:
Katherine Zukotynski | Associate Professor, McMaster University
Technology introduction
Frédéric Pouliot | Associate Professor, Université Laval
What we know and do not know from prospective PSMA imaging trials and the impact on outcomes
Featured Guest Speaker:
Stefano Fanti
Professor of Diagnostic Imaging
Director, Nuclear Medicine Division and PET Unit, The Policlinico S. Orsola,
Director, Specialty School of Nuclear Medicine, University of Bologna
Imaging and RLT context in Europe
Special Guests:
Rebecca Lo bue
General Manager, Oncidium foundation
Introducing the Oncidium foundation: Supporting the development of radiotheranostics for cancer care to enhance patient access, globally
Odile Jaume
CEO, ICPO Foundation
Improve Education and Infrastructure, Expand Patient Access to Theranostics in Precision Oncology
OBJECTIVES:
• describe the several PSMA-targeting tracers and PET/CT technology (SUVmax, SUVmean, etc.)
• describe the accuracy of PSMA-PET/CT for staging and re-staging prostate cancer based on best prospective studies
• understand the basis of PSMA radioligand therapy and the trials in metastatic prostate cancers
Supported by:
The ICPO Foundation & The Oncidium Foundation
SPONSOR:
